Plasociss-XT Tablet

Plasociss-XT Tablet belongs to haemostatic agents used in the treatment of severe menstrual bleeding. It may also be used to control excess bleeding post-surgery. Severe menstrual bleeding is defined as excessively prolonged or heavy menstrual bleeding that lasts for more than 7 days.

Plasociss-XT Tablet is composed of 'Calcium Phosphate, Citrus bioflavonoids, Menadione and Tranexamic acid. It is used to control and arrest bleeding by enhancing blood health and integrity, preventing oxidation of blood and damage that leads to shedding or bleeding. Plasociss-XT Tablet aids the natural clotting process, thereby reducing bleeding.  

Take Plasociss-XT Tablet as prescribed. Lethargy, tiredness, headache and mild joint pain are some common side effects that are seen with the use of Plasociss-XT Tablet . Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects consistently.

Before taking this medicine, inform the doctor if you have any known pre-existing allergies, thromboembolic disorder, cardiovascular disorder, hypersensitivity, or irregular menstrual bleeding. Please consult your doctor before taking Plasociss-XT Tablet during pregnancy or if you are breastfeeding. It is not advisable to consume alcohol with Plasociss-XT Tablet .

Plasociss-XT Tablet is a haemostatic agent. It contains Calcium Phosphate, Citrus bioflavonoids, Menadione and Tranexamic acid. Calcium is an important mineral in the blood clotting process. Thus, calcium phosphate promotes the natural mechanism of blood clotting. Citrus flavonoids enhance the integrity of endothelial cells including that of the uterus and prevent excess shedding or bleeding. In addition, they also act as antioxidants and prevent damage to the uterine lining by controlling prostaglandin levels. Menadione functions as a co-factor in enhancing the activity of blood proteins and clotting factors, therefore making blood tougher and stronger.  Tranexamic acid is an antifibrinolytic (prevents dissolution of fibrin, a major blood component required for the normal clotting of blood), thereby promoting circulation and healing.

Plasociss-XT Tablet is not recommended in those with established thromboembolic or clotting disorders. Plasociss-XT Tablet should not be used in case of any known allergy to either of the components. Plasociss-XT Tablet is unsafe for use during pregnancy. Keep your doctor informed if you are breastfeeding. It is advisable not to consume Plasociss-XT Tablet with alcohol nor in conjunction with certain anti-anxiety medications, anti-clot forming drugs that promote bleeding, or painkillers whose most common side-effect is bleeding. Inform the doctor right away about any medications that you are currently on, about any previous or impending surgeries, and offer a detailed medical history.

• Exercise caution in case of a history of thromboembolic disorders, cardiovascular disturbances, renal impairment, menorrhagia, haemophilia, DIC and subarachnoid bleeding (brain haemorrhage).
• Please inform the doctor immediately if you notice any anaphylaxis (allergy, skin changes, difficulty in breathing, anxiety, confusion, dizziness etc.) or if you are pregnant or breastfeeding.
• Do not take Plasociss-XT Tablet for more than three months without expert supervision.
• If you do not notice any improvement after eight weeks, please keep the doctor informed.
• Your doctor may advise routine blood tests to check for any anaemia as this is a common side-effect with Plasociss-XT Tablet .